151. The development of cowpea mosaic virus as a potential source of novel vaccines.
- Author
-
Porta C, Spall VE, Lin T, Johnson JE, and Lomonossoff GP
- Subjects
- AIDS Vaccines immunology, Amino Acid Sequence, Comovirus immunology, Comovirus pathogenicity, Comovirus ultrastructure, HIV Envelope Protein gp41 genetics, HIV Envelope Protein gp41 immunology, HIV-1 genetics, Humans, Molecular Sequence Data, Pisum sativum virology, Rhinovirus genetics, Vaccines, Synthetic immunology, Viral Proteins genetics, Viral Proteins immunology, Viral Vaccines immunology, AIDS Vaccines biosynthesis, Comovirus genetics, Genetic Vectors, HIV-1 immunology, Rhinovirus immunology, Vaccines, Synthetic biosynthesis, Viral Vaccines biosynthesis
- Abstract
Epitopes from human rhinovirus 14 (HRV-14) and human immunodeficiency virus type (HIV-1) have been expressed on the surface of particles of the plant virus, cowpea mosaic virus (CPMV). The chimaeras retain their ability to grow in plants and large quantities of virions can be easily purified. Immunological studies have shown that purified particles have the antigenic properties of the insert, and, in the case of the HIV-1 chimaera, can elicit the production of neutralising antibodies in mice. The chimaera containing the epitope from HRV-14 has been crystallised and the crystals shown to diffract to atomic resolution.
- Published
- 1996
- Full Text
- View/download PDF